NASDAQ:BMRN BioMarin Pharmaceutical - BMRN Insider Trading & Ownership Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding BioMarin Pharmaceutical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $91.50 +0.76 (+0.84%) (As of 03/27/2023 12:00 AM ET) Add Compare Share Share Today's Range$91.10▼$92.1050-Day Range$87.74▼$117.2752-Week Range$70.73▼$117.77Volume1.08 million shsAverage Volume1.57 million shsMarket Capitalization$17.07 billionP/E Ratio123.65Dividend YieldN/APrice Target$118.15 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability BioMarin Pharmaceutical (NASDAQ:BMRN) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage1.75%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$314,468.75Number OfInsiders Selling(Last 12 Months)7Amount OfInsider Selling(Last 12 Months)$26.25 M BMRN Insider Buying and Selling by Quarter Get BMRN Insider Trade Alerts Want to know when executives and insiders are buying or selling BioMarin Pharmaceutical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address BioMarin Pharmaceutical Insider Trades History Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails3/13/2023Jean Jacques BienaimeCEOSell8,000$90.45$723,600.00487,856 3/10/2023Jean Jacques BienaimeCEOSell15,000$92.28$1,384,200.00487,856 2/13/2023Jean Jacques BienaimeCEOSell6,000$109.15$654,900.00320,324 2/10/2023Jean Jacques BienaimeCEOSell15,000$110.11$1,651,650.00320,324 1/25/2023Jeffrey Robert AjerEVPSell49,000$115.70$5,669,300.0041,088 1/17/2023Jean Jacques BienaimeCEOSell10,000$111.55$1,115,500.00320,424 1/13/2023Brian MuellerCFOSell2,500$114.50$286,250.0027,746 1/13/2023Jean Jacques BienaimeCEOSell10,000$112.25$1,122,500.00320,424 12/13/2022Brian MuellerCFOSell2,500$107.50$268,750.0027,746 12/13/2022Jean Jacques BienaimeCEOSell1,000$106.89$106,890.00320,424 12/2/2022Brian MuellerCFOSell7,001$104.50$731,604.5027,746 12/2/2022Jean Jacques BienaimeCEOSell1,500$103.98$155,970.00321,424 11/23/2022Brian MuellerCFOSell5,379$98.73$531,068.6728,847 11/2/2022Jeffrey Robert AjerEVPSell3,000$86.12$258,360.0041,088 10/31/2022Jean Jacques BienaimeCEOSell1,500$86.55$129,825.00322,824 10/31/2022Mark J AllesDirectorBuy3,625$86.75$314,468.7510,905 10/14/2022Jean Jacques BienaimeCEOSell4,000$89.89$359,560.00324,324 8/15/2022Jean Jacques BienaimeCEOSell3,000$95.21$285,630.00328,324 8/12/2022Jean Jacques BienaimeCEOSell4,000$94.75$379,000.00331,324 8/11/2022Jeffrey Robert AjerEVPSell3,000$95.62$286,860.0044,088 8/8/2022Charles Greg GuyerEVPSell6,205$96.56$599,154.8042,168 7/8/2022Brian MuellerCFOSell7,337$89.50$656,661.5030,726 7/8/2022George Eric DavisEVPSell7,398$90.00$665,820.0058,941 5/26/2022Jeffrey Robert AjerEVPSell1,308$78.94$103,253.5254,109 5/5/2022Jean Jacques BienaimeCEOSell10,000$84.14$841,400.00335,324 5/4/2022Brian MuellerCFOSell11,800$84.50$997,100.0038,639 5/2/2022George Eric DavisEVPSell15,347$80.38$1,233,591.8666,339 5/2/2022Richard A MeierDirectorSell3,878$82.09$318,345.02104,014 4/28/2022Jean Jacques BienaimeCEOSell20,000$83.79$1,675,800.00334,983 4/18/2022Jean Jacques BienaimeCEOSell20,000$81.91$1,638,200.00334,983 4/14/2022Jean Jacques BienaimeCEOSell10,000$83.66$836,600.00334,983 4/14/2022V Bryan LawlisDirectorSell4,250$83.66$355,555.0023,970 4/13/2022Jeffrey Robert AjerEVPSell1,180$82.47$97,314.6055,077 3/29/2022Jeffrey Robert AjerEVPSell1,618$79.43$128,517.74 (Data available from 1/1/2013 forward) BMRN Insider Trading Activity - Frequently Asked Questions Who is on BioMarin Pharmaceutical's Insider Roster? The list of insiders at BioMarin Pharmaceutical includes Brian Mueller, Charles Greg Guyer, David E I Pyott, Dennis Slamon, George Eric Davis, Henry J Fuchs, Jean Jacques Bienaime, Jeffrey Robert Ajer, Mark J Alles, Michael G Grey, Richard A Meier, V Bryan Lawlis, and Willard H Dere. Learn more on insiders at BMRN. What percentage of BioMarin Pharmaceutical stock is owned by insiders? 1.75% of BioMarin Pharmaceutical stock is owned by insiders. Learn more on BMRN's insider holdings. Which BioMarin Pharmaceutical insiders have been buying company stock? The following insider purchased BMRN shares in the last 24 months: Mark J Alles ($314,468.75). How much insider buying is happening at BioMarin Pharmaceutical? Insiders have purchased a total of 3,625 BMRN shares in the last 24 months for a total of $314,468.75 bought. Which BioMarin Pharmaceutical insiders have been selling company stock? The following insiders have sold BMRN shares in the last 24 months: Brian Mueller ($4,439,099.77), Charles Greg Guyer ($599,154.80), Dennis Slamon ($500,998.68), George Eric Davis ($2,979,116.39), Jean Jacques Bienaime ($18,695,534.77), Jeffrey Robert Ajer ($7,367,556.85), Richard A Meier ($715,574.86), and V Bryan Lawlis ($727,897.50). How much insider selling is happening at BioMarin Pharmaceutical? Insiders have sold a total of 394,745 BioMarin Pharmaceutical shares in the last 24 months for a total of $36,024,933.62 sold. This page (NASDAQ:BMRN) was last updated on 3/28/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.